Finn K. Hansen

2.8k total citations
101 papers, 1.9k citations indexed

About

Finn K. Hansen is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Finn K. Hansen has authored 101 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Molecular Biology, 37 papers in Organic Chemistry and 37 papers in Oncology. Recurrent topics in Finn K. Hansen's work include Histone Deacetylase Inhibitors Research (71 papers), Peptidase Inhibition and Analysis (34 papers) and Protein Degradation and Inhibitors (34 papers). Finn K. Hansen is often cited by papers focused on Histone Deacetylase Inhibitors Research (71 papers), Peptidase Inhibition and Analysis (34 papers) and Protein Degradation and Inhibitors (34 papers). Finn K. Hansen collaborates with scholars based in Germany, United States and Australia. Finn K. Hansen's co-authors include Thomas Kurz, Matthias U. Kassack, Alexandra Hamacher, Holger Gohlke, Nina Reßing, Andrea Schöler, Linda Marek, David W. Christianson, Achim Aigner and Thomas Büch and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Chemical Communications.

In The Last Decade

Finn K. Hansen

93 papers receiving 1.9k citations

Peers

Countries citing papers authored by Finn K. Hansen

Since Specialization

Citations

This map shows the geographic impact of Finn K. Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finn K. Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finn K. Hansen more than expected).

Fields of papers citing papers by Finn K. Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Finn K. Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finn K. Hansen. The network helps show where Finn K. Hansen may publish in the future.

Co-authorship network of co-authors of Finn K. Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Finn K. Hansen. A scholar is included among the top collaborators of Finn K. Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Finn K. Hansen. Finn K. Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Recommended Tool Compounds: Isoform- and Class-Specific Histone Deacetylase Inhibitors 2026 ·ACS Pharmacology & Translational Science ·(unknown), Finn K. Hansen	0
2	Discovery of Histone Deacetylase 8-Specific Proteolysis-Targeting Chimeras with Anticancer Activity against Hematological Malignancies 2026 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michael Gütschow, Radosław P. Nowak, Christian Steinebach, Sanil Bhatia, Finn K. Hansen	0
3	Development of Ethyl-Hydrazide-Based Selective Histone Deacetylase 6 (HDAC6) PROTACs 2025 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Finn K. Hansen	7
4	Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase Degraders 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Heiko B. Weber, (unknown), (unknown), Finn K. Hansen	8
5	Replacing a Cereblon Ligand by a DDB1 and CUL4 Associated Factor 11 (DCAF11) Recruiter Converts a Selective Histone Deacetylase 6 PROTAC into a Pan‐Degrader 2025 ·ChemMedChem ·(unknown), Heiko B. Weber, (unknown), (unknown), (unknown), Finn K. Hansen	4
6	Exploring Alternative Zinc-Binding Groups in Histone Deacetylase (HDAC) Inhibitors Uncovers DS-103 as a Potent Ethylhydrazide-Based HDAC Inhibitor with Chemosensitizing Properties 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), P. R. Watson, Jingyu Li, (unknown), (unknown), Laís Pessanha de Carvalho, Jana Klose, (unknown), Alexandra Hamacher, Linda Schäker‐Hübner, (unknown), Jana Held, David W. Christianson, Matthias U. Kassack, Finn K. Hansen	5
7	Ortho -Hydroxyanilides: Slow-Acting, Selective Histone Deacetylase 1/2 Inhibitors Suitable for Photocaging Applications 2025 ·ACS Pharmacology & Translational Science ·(unknown), Tung‐Tien Sun, (unknown), Linda Schäker‐Hübner, Finn K. Hansen	0
8	A Fluorescent Probe Enables the Discovery of Improved Antagonists Targeting the Intracellular Allosteric Site of the Chemokine Receptor CCR7 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Nicole Merten, (unknown), Teresa M Steffen, Yinshui Chang, (unknown), Dirk Baumjohann, Eva Kiermaier, Peter Kolb, Evi Kostenis, Matthias Schiedel, Finn K. Hansen	3
9	Development of peptoid-based heteroaryl-decorated histone deacetylase (HDAC) inhibitors with dual-stage antiplasmodial activity 2024 ·European Journal of Medicinal Chemistry ·(unknown), Laís Pessanha de Carvalho, (unknown), (unknown), Elizabeth A. Winzeler, Jana Held, Finn K. Hansen	2
10	Micro-scale screening of genetically modified Fusarium fujikuroi strain extends the apicidin family 2024 ·Natural Products and Bioprospecting ·(unknown), (unknown), Florian Hübner, Linda Schäker‐Hübner, (unknown), Finn K. Hansen, Svetlana A. Kalinina	1
11	Triple Combination of Entinostat, a Bromodomain Inhibitor, and Cisplatin Is a Promising Treatment Option for Bladder Cancer 2024 ·Cancers ·(unknown), (unknown), Alexandra Hamacher, (unknown), Linda Schäker‐Hübner, Finn K. Hansen, Matthias U. Kassack	1
12	Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties 2024 ·Bioorganic Chemistry ·(unknown), (unknown), (unknown), (unknown), Andrea Schöler, Shannon T. Smith, Jens Meiler, Linda Schäker‐Hübner, Günther Weindl, Finn K. Hansen	9
13	Development of a NanoBRET Assay Platform to Detect Intracellular Ligands for the Chemokine Receptors CCR6 and CXCR1 2024 ·ChemMedChem ·(unknown), (unknown), Aurélien F. A. Moumbock, (unknown), Evi Kostenis, (unknown), Martyna Szpakowska, (unknown), Stefan Günther, Finn K. Hansen, Matthias Schiedel	2
14	HDAC inhibitors activate lipid peroxidation and ferroptosis in gastric cancer 2024 ·Biochemical Pharmacology ·(unknown), (unknown), (unknown), (unknown), Linda Schäker‐Hübner, Finn K. Hansen, Florian Lordick, (unknown), Achim Aigner, Thomas Büch	18
15	Targeted Protein Degradation of Histone Deacetylases by Hydrophobically Tagged Inhibitors 2023 ·ACS Medicinal Chemistry Letters ·(unknown), Finn K. Hansen	10
16	Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer Therapy 2023 ·Pharmaceuticals ·(unknown), (unknown), (unknown), Linda Schäker‐Hübner, Finn K. Hansen	15
17	Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [18F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain 2022 ·Pharmaceuticals ·(unknown), Linda Schäker‐Hübner, Barbara Wenzel, Magali Toussaint, Winnie Deuther‐Conrad, Daniel Gündel, Rodrigo Teodoro, Sladjana Dukić-Stefanović, (unknown), Klaus Kopka, Peter Brust, Finn K. Hansen, Matthias Scheunemann	1
18	4-Acyl Pyrrole Capped HDAC Inhibitors: A New Scaffold for Hybrid Inhibitors of BET Proteins and Histone Deacetylases as Antileukemia Drug Leads 2021 ·Journal of Medicinal Chemistry ·Linda Schäker‐Hübner, (unknown), (unknown), Pankaj Mishra, (unknown), (unknown), Andrea Schöler, Arndt Borkhardt, Bernhard Breit, Sanil Bhatia, (unknown), Stefan Günther, Finn K. Hansen	31
19	In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi) 2020 ·International Journal of Molecular Sciences ·Annabelle Friedrich, (unknown), (unknown), (unknown), Matthias U. Kassack, Wolfgang A. Schulz, Wynand P. Roos, Finn K. Hansen, (unknown), Thomas Kurz, Gerhard Fritz	9
20	Discovery of the First-in-Class Dual Histone Deacetylase–Proteasome Inhibitor 2018 ·Journal of Medicinal Chemistry ·Sanil Bhatia, (unknown), M. Groll, J.D. Osko, Nina Reßing, (unknown), Arndt Borkhardt, Thomas Kurz, David W. Christianson, Julia Hauer, Finn K. Hansen	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact